Trial Information
Renal Mass Registry
Inclusion Criteria
Inclusion:
- Patients with a renal mass or a suspected metastatic lesion from a renal primary who
have been treated or are going to be studied and or treated surgically at Mayo Clinic
Arizona
- Patients must be 18 years of age or older
- Patients must be capable of and willing to sign an informed consent
Exclusion:
None
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label
Outcome Measure:
Evidence of Renal Mass Risk Factors as determined by patient questionnaire post surgery
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Erik Castle, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Mayo Clinic
Authority:
United States: Institutional Review Board
Study ID:
13-002688
NCT ID:
NCT01887574
Start Date:
June 2013
Completion Date:
June 2053
Related Keywords:
- Renal Cell Carcinoma
- Carcinoma
- Carcinoma, Renal Cell
Name | Location |
Mayo Clinic in Arizona |
Scottsdale, Arizona 85259-5404 |